Cagrilintide
Product Code Name: Manta Ray
Metabolic Collection
Cagrilintide is a long-acting amylin analog that helps regulate appetite, reduce caloric intake, and improve metabolic function. When combined with semaglutide, it shows remarkable results for weight loss.
Friends & Family Price
$85.00
What is Cagrilintide?
Cagrilintide is a long-acting amylin analog designed to support appetite regulation, reduced caloric intake, and improved metabolic function. It may also complement GLP-1 agonists as part of a provider-guided weight management plan.
Key Benefits
- Powerful appetite suppression via amylin receptor activation
- Slows gastric emptying and increases satiety
- Complements GLP-1 agonists for enhanced weight loss
- Improves blood sugar regulation
- May reduce food cravings and emotional eating
- Synergistic effects when stacked with semaglutide or tirzepatide
Dosing Protocol
- Starting dose: 0.16mg – 0.3mg once weekly subcutaneous injection
- Titrate up slowly every 4 weeks based on tolerance
- Often used in combination with a GLP-1 agonist
- Inject into abdomen, thigh, or upper arm — rotate sites
- Take on the same day each week
- Store refrigerated; do not freeze
What to Expect
Cagrilintide is still emerging in clinical research. Nausea is the most common side effect, especially early on. When used with a GLP-1 agonist, expect amplified appetite suppression and weight loss results.
This information is educational and is not a substitute for medical advice. Dosing, combinations, and treatment decisions should be reviewed with a qualified licensed provider.